Pulmonary Arterial Hypertension Oral and Inhaled Drugs

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required but eligible patients will encounter a co-pay at the pharmacy.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
bosentan TRACLEER TABLET Y    
sildenafil citrate REVATIO TABLET Y    
sildenafil citrate SILDENAFIL TABLET Y    
ambrisentan LETAIRIS TABLET N PA Document  
bosentan TRACLEER TAB SUSP N PA Document  
iloprost tromethamine VENTAVIS AMPUL-NEB N PA Document  
macitentan OPSUMIT TABLET N PA Document  
riociguat ADEMPAS TABLET N PA Document  
selexipag UPTRAVI TAB DS PK N PA Document  
selexipag UPTRAVI TABLET N PA Document  
sildenafil citrate REVATIO SUSP RECON N PA Document  
sildenafil citrate SILDENAFIL CITRATE TABLET N PA Document  
sildenafil citrate VIAGRA TABLET N PA Document  
tadalafil ADCIRCA TABLET N PA Document  
treprostinil TYVASO AMPUL-NEB N PA Document  
treprostinil diolamine ORENITRAM ER TABLET ER N PA Document  
treprostinil/neb accessories TYVASO REFILL KIT AMPUL-NEB N PA Document  
treprostinil/nebulizer/accesor TYVASO INSTITUTIONAL START KIT AMPUL-NEB N PA Document  
treprostinil/nebulizer/accesor TYVASO STARTER KIT AMPUL-NEB N PA Document